These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6221434

  • 1. The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium.
    Walker JE, Gow L, Campbell DM, Ogston D.
    Thromb Haemost; 1983 Feb 28; 49(1):21-3. PubMed ID: 6221434
    [Abstract] [Full Text] [Related]

  • 2. The inhibition of tissue activator and urokinase by human plasma.
    Walker JE, Ogston D.
    Thromb Haemost; 1982 Jun 28; 47(3):265-8. PubMed ID: 6180497
    [Abstract] [Full Text] [Related]

  • 3. Inhibitors of fibrinolysis in amniotic fluid.
    Walker JE, Campbell DM, Ogston D.
    Thromb Haemost; 1980 Aug 29; 44(1):32-4. PubMed ID: 6968460
    [Abstract] [Full Text] [Related]

  • 4. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.
    Stegnar M, Zore A, Novak-Antolic Z, Vovk N, Kruithof EK.
    Thromb Haemost; 1993 Sep 01; 70(3):486-90. PubMed ID: 8259554
    [Abstract] [Full Text] [Related]

  • 5. Whole-blood fibrinolytic activity in normal and hypertensive pregnancies and its relation to the placental concentration of urokinase inhibitor.
    Arias F, Andrinopoulos G, Zamora J.
    Am J Obstet Gynecol; 1979 Mar 15; 133(6):624-9. PubMed ID: 426017
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of heparin.
    Clemmensen I.
    Thromb Haemost; 1978 Jun 30; 39(3):616-23. PubMed ID: 705690
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of the plasminogen activator urokinase by alpha-tocopherol.
    Ogston D.
    Acta Haematol; 1982 Jun 30; 67(2):114-8. PubMed ID: 6801892
    [Abstract] [Full Text] [Related]

  • 8. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
    Bronisz A, Rosc D, Bronisz M, Szymanski W, Junik R.
    Med Sci Monit; 2008 Nov 30; 14(11):CR574-9. PubMed ID: 18971874
    [Abstract] [Full Text] [Related]

  • 9. Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma.
    Clemmensen I, Thorsen S, Müllertz S.
    Haemostasis; 1976 Nov 30; 5(4):218-30. PubMed ID: 826461
    [Abstract] [Full Text] [Related]

  • 10. Purification and characterization of tissue-type plasminogen activator in maxillary mucosa with chronic inflammation.
    Hamaguchi Y, Ohi M, Sakakura Y, Miyoshi Y.
    Thromb Haemost; 1985 Aug 30; 54(2):485-9. PubMed ID: 3936218
    [Abstract] [Full Text] [Related]

  • 11. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P, Kant KS, Allen C, Pollak VE.
    J Lab Clin Med; 1984 Dec 30; 104(6):962-76. PubMed ID: 6239000
    [Abstract] [Full Text] [Related]

  • 12. The fibrinolytic system in pre-eclampsia.
    Gow L, Campbell DM, Ogston D.
    J Clin Pathol; 1984 Jan 30; 37(1):56-8. PubMed ID: 6423699
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O, Rijken DC, Collen D.
    Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339
    [Abstract] [Full Text] [Related]

  • 14. Urokinase-like plasminogen activator increased in plasma after alcohol drinking.
    Sumi H, Hamada H, Tsushima H, Mihara H.
    Alcohol Alcohol; 1988 Jun 30; 23(1):33-43. PubMed ID: 3128990
    [Abstract] [Full Text] [Related]

  • 15. A site-directed mutagenesis of pro-urokinase which substantially reduces its intrinsic activity.
    Liu JN, Tang W, Sun ZY, Kung W, Pannell R, Sarmientos P, Gurewich V.
    Biochemistry; 1996 Nov 12; 35(45):14070-6. PubMed ID: 8916892
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of the activity of high and low molecular weight urokinase in the presence of fibrin.
    Samama M, Castel M, Matsuo O, Hoylaerts M, Lijnen HR.
    Thromb Haemost; 1982 Feb 26; 47(1):36-40. PubMed ID: 7041325
    [Abstract] [Full Text] [Related]

  • 17. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR.
    Behring Inst Mitt; 1983 Aug 26; (73):43-55. PubMed ID: 6236789
    [Abstract] [Full Text] [Related]

  • 18. The inhibition of urokinase by aromatic diamidines.
    Geratz JD, Cheng MC.
    Thromb Diath Haemorrh; 1975 Apr 30; 33(2):230-43. PubMed ID: 1138421
    [Abstract] [Full Text] [Related]

  • 19. Enhanced PAI-1 levels from early second trimester and during labour and plasminogen activators in normal pregnancy.
    Koh SC, Anandakumar C, Biswas A, Fong YF.
    Thromb Haemost; 2002 Jan 30; 87(1):175-6. PubMed ID: 11858184
    [No Abstract] [Full Text] [Related]

  • 20. Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy.
    Choi JW, Pai SH.
    Ann Hematol; 2002 Nov 30; 81(11):611-5. PubMed ID: 12454697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.